vs
Side-by-side financial comparison of GE HealthCare (GEHC) and Molson Coors Beverage Company (TAP). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.1B vs $2.7B, roughly 1.9× Molson Coors Beverage Company). GE HealthCare runs the higher net margin — 8.0% vs 5.5%, a 2.5% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.4% vs 2.0%). GE HealthCare produced more free cash flow last quarter ($112.0M vs $-212.9M). Over the past eight quarters, GE HealthCare's revenue compounded faster (3.0% CAGR vs -15.8%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Molson Coors Beverage Company is a Canadian-American multinational drink and brewing company headquartered in Chicago, Illinois and Montreal, Quebec.
GEHC vs TAP — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $2.7B |
| Net Profit | $411.0M | $150.1M |
| Gross Margin | 38.5% | 33.0% |
| Operating Margin | 10.0% | — |
| Net Margin | 8.0% | 5.5% |
| Revenue YoY | 7.4% | 2.0% |
| Net Profit YoY | -31.0% | 25.0% |
| EPS (diluted) | $0.85 | $0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | $2.7B | ||
| Q4 25 | $5.7B | $3.1B | ||
| Q3 25 | $5.1B | $3.5B | ||
| Q2 25 | $5.0B | $3.7B | ||
| Q1 25 | $4.8B | $2.7B | ||
| Q4 24 | $5.3B | $3.2B | ||
| Q3 24 | $4.9B | $3.6B | ||
| Q2 24 | $4.8B | $3.8B |
| Q1 26 | $411.0M | $150.1M | ||
| Q4 25 | $588.0M | $238.3M | ||
| Q3 25 | $446.0M | $-2.9B | ||
| Q2 25 | $486.0M | $428.7M | ||
| Q1 25 | $564.0M | $121.0M | ||
| Q4 24 | $721.0M | $287.8M | ||
| Q3 24 | $470.0M | $199.8M | ||
| Q2 24 | $428.0M | $427.0M |
| Q1 26 | 38.5% | 33.0% | ||
| Q4 25 | 39.7% | 31.0% | ||
| Q3 25 | 38.7% | 33.7% | ||
| Q2 25 | 39.6% | 34.3% | ||
| Q1 25 | 42.1% | 31.6% | ||
| Q4 24 | 42.8% | 32.0% | ||
| Q3 24 | 41.7% | 33.4% | ||
| Q2 24 | 41.4% | 34.6% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 14.5% | 10.4% | ||
| Q3 25 | 12.7% | -98.5% | ||
| Q2 25 | 13.1% | 15.6% | ||
| Q1 25 | 13.2% | 6.9% | ||
| Q4 24 | 15.1% | 12.0% | ||
| Q3 24 | 13.9% | 12.5% | ||
| Q2 24 | 12.6% | 15.6% |
| Q1 26 | 8.0% | 5.5% | ||
| Q4 25 | 10.3% | 7.6% | ||
| Q3 25 | 8.7% | -84.0% | ||
| Q2 25 | 9.7% | 11.5% | ||
| Q1 25 | 11.8% | 4.5% | ||
| Q4 24 | 13.6% | 8.9% | ||
| Q3 24 | 9.7% | 5.5% | ||
| Q2 24 | 8.8% | 11.1% |
| Q1 26 | $0.85 | $0.80 | ||
| Q4 25 | $1.28 | $1.32 | ||
| Q3 25 | $0.98 | $-14.79 | ||
| Q2 25 | $1.06 | $2.13 | ||
| Q1 25 | $1.23 | $0.59 | ||
| Q4 24 | $1.58 | $1.39 | ||
| Q3 24 | $1.02 | $0.96 | ||
| Q2 24 | $0.93 | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $382.6M |
| Total DebtLower is stronger | $10.1B | $3.8B |
| Stockholders' EquityBook value | $10.7B | $10.3B |
| Total Assets | $37.1B | $22.4B |
| Debt / EquityLower = less leverage | 0.95× | 0.38× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $382.6M | ||
| Q4 25 | $4.5B | $896.5M | ||
| Q3 25 | $4.0B | $950.2M | ||
| Q2 25 | $3.7B | $613.8M | ||
| Q1 25 | $2.5B | $412.7M | ||
| Q4 24 | $2.9B | $969.3M | ||
| Q3 24 | $3.5B | $1.0B | ||
| Q2 24 | $2.0B | $1.6B |
| Q1 26 | $10.1B | $3.8B | ||
| Q4 25 | $10.0B | $6.3B | ||
| Q3 25 | $10.3B | $6.3B | ||
| Q2 25 | $10.3B | $6.3B | ||
| Q1 25 | $8.8B | $6.2B | ||
| Q4 24 | $9.0B | $6.1B | ||
| Q3 24 | $10.3B | $6.2B | ||
| Q2 24 | $9.2B | $7.0B |
| Q1 26 | $10.7B | $10.3B | ||
| Q4 25 | $10.4B | $10.2B | ||
| Q3 25 | $10.0B | $10.3B | ||
| Q2 25 | $9.7B | $13.4B | ||
| Q1 25 | $9.2B | $13.1B | ||
| Q4 24 | $8.4B | $13.1B | ||
| Q3 24 | $8.3B | $13.3B | ||
| Q2 24 | $7.8B | $13.2B |
| Q1 26 | $37.1B | $22.4B | ||
| Q4 25 | $36.9B | $22.7B | ||
| Q3 25 | $36.1B | $22.9B | ||
| Q2 25 | $35.5B | $26.8B | ||
| Q1 25 | $33.6B | $25.9B | ||
| Q4 24 | $33.1B | $26.1B | ||
| Q3 24 | $33.9B | $26.6B | ||
| Q2 24 | $31.9B | $27.4B |
| Q1 26 | 0.95× | 0.38× | ||
| Q4 25 | 0.96× | 0.61× | ||
| Q3 25 | 1.03× | 0.61× | ||
| Q2 25 | 1.06× | 0.47× | ||
| Q1 25 | 0.95× | 0.47× | ||
| Q4 24 | 1.06× | 0.47× | ||
| Q3 24 | 1.24× | 0.47× | ||
| Q2 24 | 1.18× | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | $112.0M | $-212.9M |
| FCF MarginFCF / Revenue | 2.2% | -7.8% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $540.7M | ||
| Q3 25 | — | $616.1M | ||
| Q2 25 | $94.0M | $718.3M | ||
| Q1 25 | $250.0M | $-90.7M | ||
| Q4 24 | — | $494.5M | ||
| Q3 24 | — | $521.2M | ||
| Q2 24 | $-119.0M | $869.2M |
| Q1 26 | $112.0M | $-212.9M | ||
| Q4 25 | — | $357.8M | ||
| Q3 25 | — | $483.0M | ||
| Q2 25 | $8.0M | $555.0M | ||
| Q1 25 | $98.0M | $-328.0M | ||
| Q4 24 | — | $383.4M | ||
| Q3 24 | — | $350.4M | ||
| Q2 24 | $-183.0M | $691.7M |
| Q1 26 | 2.2% | -7.8% | ||
| Q4 25 | — | 11.4% | ||
| Q3 25 | — | 13.9% | ||
| Q2 25 | 0.2% | 14.8% | ||
| Q1 25 | 2.1% | -12.2% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | -3.8% | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 5.9% | ||
| Q3 25 | 2.1% | 3.8% | ||
| Q2 25 | 1.7% | 4.4% | ||
| Q1 25 | 3.2% | 8.8% | ||
| Q4 24 | 1.9% | 3.4% | ||
| Q3 24 | 1.9% | 4.7% | ||
| Q2 24 | 1.3% | 4.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.27× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.19× | 1.68× | ||
| Q1 25 | 0.44× | -0.75× | ||
| Q4 24 | — | 1.72× | ||
| Q3 24 | — | 2.61× | ||
| Q2 24 | -0.28× | 2.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
TAP
Segment breakdown not available.
